Site Analysis Period definition

Site Analysis Period means the period commencing on the Effective Date (as defined in Paragraph 21(a) herein) and expiring at 5:00 p.m. EST on March 24, 1997. If Buyer determines in Buyer's sole and absolute discretion that the Property is unacceptable, then Buyer shall have the right to terminate this Agreement by giving written notice of termination to Seller prior to the expiration of the Site Analysis Period, in which event Seller and Buyer shall pay their respective costs incurred as of the termination date in accordance with Paragraph 10 hereof and neither Party shall have any further rights or obligations hereunder except for the Indemnification Obligations (as herein defined). In the event Buyer fails to terminate this Agreement prior to the expiration of the Site Analysis Period, as same may be extended in writing by mutual agreement of Buyer and Seller, except in the case of a default by Seller hereunder (which shall be governed by the terms of Paragraph 14.b herein) and except in the event of a termination of this Agreement by either party pursuant to any specific termination rights set forth herein which requires the return of the Binder Deposit to Buyer, the Binder Deposit shall be paid over to the Escrow Agent in accordance with Paragraph 3 and shall be deemed for all purposes under this Agreement to be non-refundable to Buyer. Buyer agrees that it will forward to Seller copies of all reports and due diligence materials and information obtained by Buyer relative to the Property within a reasonable time after receipt of same. At Closing, the Binder Deposit shall be applied to the Purchase Price or, at the election of Buyer and provided substitute proceeds are delivered to Seller at Closing, returned to Buyer. Seller agrees that all vacant apartment units at the Property shall be maintained in "rent ready" condition in a manner which is consistent with the past practices of Seller at the Property relative to vacated units. All apartment units vacant or vacated at least five days (5) prior to Closing shall be in a "rent ready" condition at Closing and shall contain, without limitation, the following: carpet, refrigerator, range, garbage disposal, heating, plumbing and electrical systems.
Sample 1
Site Analysis Period means the period expiring on June 17, 1996. If the Project is determined to be unacceptable to Purchaser, for any reason whatsoever, in Purchaser's sole discretion, Purchaser shall have the right to terminate this Agreement by giving written notice of termination on or prior to the date of expiration of the Site Analysis Period, in which event the Deposit shall be returned to Purchaser. In accordance with the provisions of 11.02(b) hereof, Seller and Purchaser shall each pay 50% of the Shared Closing Costs incurred as of the termination date, and neither Party shall have any further rights or obligations hereunder, except those specifically provided herein that survive the termination of this Agreement. A failure to so notify Seller of Purchaser's election to terminate or proceed with this Agreement as aforesaid prior to the expiration of the Site Analysis Period shall be deemed as notice to Seller that Purchaser has elected to terminate this Agreement as aforesaid.
Sample 1Sample 2
Site Analysis Period means the period expiring on June 17, 1996. If the Project is determined to be unacceptable to Purchaser, for any reason whatsoever, in Purchaser's sole discretion, Purchaser shall have the right to terminate this Agreement by giving written notice of termination on or prior to the date of expiration of the Site Analysis Period, in which event the Deposit shall be returned to Purchaser and the Lump Sum Payment shall be retained and deemed earned by Seller. In accordance with the provisions of 11.02(b) hereof, Seller and Purchaser shall each pay 50% of the Shared Closing Costs incurred as of the termination date, and neither
Sample 1

Examples of Site Analysis Period in a sentence

  • Purchaser shall have the Site Analysis Period in which to conduct the Tests and Studies and to ascertain whether the Project is acceptable to Purchaser.

  • Twenty-Five Thousand and 00/100 Dollars ($25,000.00) (the "Second Deposit") which Purchaser shall deposit with Escrow Agent on the expiration date of the Site Analysis Period (as hereinafter defined), if Purchaser elects to proceed with this transaction, as more fully provided in Paragraph 5.03 below (the Initial Deposit and the Second Deposit are hereinafter collectively referred to as the "Deposit").

  • Seller shall cause an "as-built" Survey (the "Survey") of the Real Property to be updated during the Site Analysis Period.

  • The Site Analysis Period shall also include that thirty (30) day period on and after the Phase II Notice Date (as hereinafter defined) for those Tests and Studies on Phase II Purchaser chooses to conduct in respect to those Improvements completed on Phase II after June 17, 1996.

  • In the event Purchaser discovers what it deems to be Unacceptable Conditions as a result of the Tests and Studies, Purchaser shall notify ("Condition Notice") Seller, in writing, of the same promptly following Purchaser's discovery thereof, but in no instance later than three (3) business days following the expiration of the Site Analysis Period.

  • Seller acknowledges that to enable Purchaser to proceed with this transaction, Purchaser already has and, during the Site Analysis Period (as hereinafter defined), may undertake or cause to have undertaken tests and studies, including, but not limited to, marketing, engineering, environmental, feasibility and soil that Purchaser, in its reasonable discretion, deems necessary to determine the feasibility of its acquisition of the Project (hereinafter collectively referred to as "Tests and Studies").

  • A failure to so notify Seller of Purchaser's election to terminate or proceed with this Agreement as aforesaid prior to the expiration of the Site Analysis Period shall be deemed as notice to Seller that Purchaser has elected to terminate this Agreement as aforesaid.

  • If the Project is determined to be unacceptable to Purchaser, for any reason whatsoever, in Purchaser's sole discretion, Purchaser shall have the right to terminate this Agreement by giving written notice of termination on or prior to the date of expiration of the Site Analysis Period, in which event the Deposit shall be returned to Purchaser.

  • The "Site Analysis Period" shall mean the period commencing on the Effective Date (as defined in Paragraph 21(a) herein) and expiring at 5:00 p.m. EST on March 24, 1997.

  • Upon expiration of the Site Analysis Period (as herein defined), Buyer shall pay and deliver to The Title Company of North Carolina, Inc.

Related to Site Analysis Period

  • Root Cause Analysis Report means a report addressing a problem or non-conformance, in order to get to the ‘root cause’ of the problem, which thereby assists in correcting or eliminating the cause, and prevent the problem from recurring.

  • Feasibility Study means the evaluation and analysis of the potential of a project, which aims at supporting the process of decision-making by objectively and rationally uncovering its strengths and weaknesses, opportunities and threats, as well as identifying the resources required to carry it through and ultimately its prospects for success;

  • Development Phase means the period before a vehicle type is type approved.

  • Cost Analysis means the evaluation of cost data for the purpose of arriving at estimates of costs to be incurred, prices to be paid, costs to be reimbursed, or costs actually incurred.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Forensic analysis means the practice of gathering, retaining, and analyzing computer-related data for investigative purposes in a manner that maintains the integrity of the data.

  • Phase III Clinical Study means a pivotal Clinical Study, the results of which could be used to establish safety and efficacy of a Licensed Product in the Field as a basis for Regulatory Approval or that would otherwise satisfy requirements of 21 CFR 312.21(c), or its foreign equivalent.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Development Report means a written account of Licensee’s progress under the Development Plan having at least the information specified on Appendix B to this Agreement, and shall be sent to the address specified on Appendix B.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients designated as a Phase I Trial and conducted primarily for the purpose of determining the safety of and/or the metabolism and pharmacologic actions of the Licensed Product in humans, as described under 21 CFR § 312.21(a) (as hereafter modified or amended) and any of its foreign equivalents. For purposes of this definition, Phase I Trial shall specifically exclude trials in healthy volunteers.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Phase II Clinical Trial means a study in humans of the safety, dose ranging and efficacy of a product, which is prospectively designed to generate sufficient data (if successful) to commence a Phase III Clinical Trial or to file for accelerated approval, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(b) or its foreign equivalents.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Development Period means the period from the date of this Agreement until the Appointed Date;

  • Phase II Trial means a clinical trial of a Licensed Product, designated as a Phase II Trial and the principal purpose of which is to make a preliminary determination that such Licensed Product is safe and active in a patient population for its intended use and is designed to obtain sufficient information about such Licensed Product’s efficacy to permit the design of a Phase III Trial(s), and generally consistent with 21 CFR § 312.21(b). For purposes of this definition, Phase II trial shall specifically exclude expansion cohorts from Phase I Trial(s).